157 related articles for article (PubMed ID: 21392510)
1. The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21.
Gupte J; Yang L; Wu X; Weiszmann J; Hecht R; Lemon B; Lindberg R; Wang Z; Li Y
J Mol Biol; 2011 May; 408(3):491-502. PubMed ID: 21392510
[TBL] [Abstract][Full Text] [Related]
2. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling.
Yie J; Wang W; Deng L; Tam LT; Stevens J; Chen MM; Li Y; Xu J; Lindberg R; Hecht R; Véniant M; Chen C; Wang M
Chem Biol Drug Des; 2012 Apr; 79(4):398-410. PubMed ID: 22248288
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
[TBL] [Abstract][Full Text] [Related]
4. Different roles of N- and C- termini in the functional activity of FGF21.
Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network.
Xu R; Rudd TR; Hughes AJ; Siligardi G; Fernig DG; Yates EA
FEBS J; 2013 May; 280(10):2260-70. PubMed ID: 23441759
[TBL] [Abstract][Full Text] [Related]
6. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
[TBL] [Abstract][Full Text] [Related]
7. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases.
Zhao L; Niu J; Lin H; Zhao J; Liu Y; Song Z; Xiang C; Wang X; Yang Y; Li X; Mohammadi M; Huang Z
EBioMedicine; 2019 Oct; 48():462-477. PubMed ID: 31631034
[TBL] [Abstract][Full Text] [Related]
8. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
[TBL] [Abstract][Full Text] [Related]
9. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
[TBL] [Abstract][Full Text] [Related]
10. FGF21 N- and C-termini play different roles in receptor interaction and activation.
Yie J; Hecht R; Patel J; Stevens J; Wang W; Hawkins N; Steavenson S; Smith S; Winters D; Fisher S; Cai L; Belouski E; Chen C; Michaels ML; Li YS; Lindberg R; Wang M; Véniant M; Xu J
FEBS Lett; 2009 Jan; 583(1):19-24. PubMed ID: 19059246
[TBL] [Abstract][Full Text] [Related]
11. FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho.
Kharitonenkov A; Dunbar JD; Bina HA; Bright S; Moyers JS; Zhang C; Ding L; Micanovic R; Mehrbod SF; Knierman MD; Hale JE; Coskun T; Shanafelt AB
J Cell Physiol; 2008 Apr; 215(1):1-7. PubMed ID: 18064602
[TBL] [Abstract][Full Text] [Related]
12. Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail.
Sørensen V; Wiedlocha A; Haugsten EM; Khnykin D; Wesche J; Olsnes S
J Cell Sci; 2006 Oct; 119(Pt 20):4332-41. PubMed ID: 17003104
[TBL] [Abstract][Full Text] [Related]
13. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
[TBL] [Abstract][Full Text] [Related]
14. Amino acid residues which distinguish the mitogenic potentials of two FGF receptors.
Wang JK; Goldfarb M
Oncogene; 1997 Apr; 14(15):1767-78. PubMed ID: 9150382
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL; Kan M
Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
[TBL] [Abstract][Full Text] [Related]
16. The glycine box: a determinant of specificity for fibroblast growth factor.
Luo Y; Lu W; Mohamedali KA; Jang JH; Jones RB; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1998 Nov; 37(47):16506-15. PubMed ID: 9843417
[TBL] [Abstract][Full Text] [Related]
17. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
Aviezer D; Safran M; Yayon A
Biochem Biophys Res Commun; 1999 Oct; 263(3):621-6. PubMed ID: 10512728
[TBL] [Abstract][Full Text] [Related]
18. Expression profile and overexpression outcome indicate a role for βKlotho in skeletal muscle fibro/adipogenesis.
Phelps M; Stuelsatz P; Yablonka-Reuveni Z
FEBS J; 2016 May; 283(9):1653-68. PubMed ID: 26881702
[TBL] [Abstract][Full Text] [Related]
19. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
[TBL] [Abstract][Full Text] [Related]
20. Competition for ligands between FGFR1 and FGFR4 regulates Xenopus neural development.
Yamagishi M; Okamoto H
Int J Dev Biol; 2010; 54(1):93-104. PubMed ID: 20013652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
